[1]
“A REVIEW OF OZEMPIC’S OFF LABEL USE FOR WEIGHT LOSS IN NON-DIABETIC INDIVIDUALS: CLINICAL EVIDENCE, SAFETY AND ETHICS”, Biosci. Insights., vol. 3, no. 3, pp. 48–53, Oct. 2026, Accessed: Nov. 13, 2026. [Online]. Available: https://www.biosciinsights.com/index.php/BI/article/view/188